In 1988, 88 flea beetles were released in North Dakota to fight leafy spurge. By 1994, stems fell from 182 to five per square ...
The AI company’s first public financial disclosures reveal explosive growth, huge costs and risks ranging from cyber-attacks ...
Tech Times on MSN
Cell therapy maker Pluri takes 50% of ZEO to crack regenerative medicine's $400K cost floor
Regenerative medicine commercialization advanced October 26, 2026, as Pluri Inc. and ZEO ScientifiX announced a 50-50 equity ...
The company promises to help solve humanity’s most difficult problems while warning that its technology could threaten ...
Many local companies want to contribute to their communities. However, they often struggle with the barriers of "Is that ...
GrOwnValve GmbH, a Berlin-based medical technology company developing personalized heart valves from patients' own tissue, ...
AM ET SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value ...
We are entering a phase in which understanding differences between markets, identifying where growth is actually occurring ...
Oral vitamin C improved OS in patients with CCUS or lower-risk myeloid malignancies in the EVITA trial despite missing the clonal growth primary end point. Although the phase 2 EVITA trial ...
Anthropic filed for an IPO on Monday, bringing closer what could be one of the largest public debuts in stock market history.
New York-based Pathos AI has secured $237 million in Series E financing at a post-money valuation of approximately $3 billion ...
Healey's Budget AI investment package includes £165m for biosecurity, £120m for the AI Security Institute and £60m more for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results